Sign up HERE to receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on LinkedIn for updates.
Endocare plans to launch its obesity and metabolic care services in Riyadh within the coming months, building on its successful operations in Dubai and Abu Dhabi.

SAUDI ARABIA—Endocare, one of the UAE’s fastest-growing obesity and metabolic healthcare providers, is set to expand into Saudi Arabia through a strategic partnership with The Clinics, a prominent multispecialty medical group based in Riyadh.
The collaboration marks a significant step in Endocare’s regional growth strategy as it brings its specialized care model to the Kingdom.
Leyla Azizova, founder and CEO of Endocare, and Dr. Tariq Alshenaifi, medical director and chairman of The Clinics, formalized the partnership by signing a Memorandum of Understanding (MoU).
This agreement reflects both organizations’ commitment to delivering high-quality metabolic care to patients in Saudi Arabia.
Endocare plans to launch its obesity and metabolic care services in Riyadh within the coming months, building on its successful operations in Dubai and Abu Dhabi.
The expansion represents a critical milestone as the company scales its clinically integrated care model across key Gulf Cooperation Council (GCC) markets.
The healthcare provider has built its reputation on a structured, outcomes-focused approach that addresses obesity and metabolic health through a comprehensive framework.
Endocare combines medical treatment, advanced diagnostics, and lifestyle interventions within a single coordinated care pathway.
This integrated model has established the company as a trusted partner for patients and corporate clients tackling one of the region’s most pressing health challenges.
“Our expansion into Saudi Arabia reflects the strong demand we are seeing across the region for specialized, evidence-based metabolic care,” Azizova explained.
She emphasized that partnering with The Clinics enables Endocare to enter the Riyadh market with local expertise, clinical depth, and the speed necessary to meet growing demand while maintaining the high standards that have driven the company’s success in the UAE.
Dr. Alshenaifi highlighted the strategic value of the partnership, noting that Endocare brings a highly specialized and structured approach to obesity and metabolic health.
He expressed confidence in the alignment between both organizations’ values and clinical philosophies, adding that The Clinics looks forward to offering these advanced services to its patient community in Riyadh.
The partnership arrives at a pivotal moment as healthcare systems across the Gulf region increasingly prioritize metabolic health, chronic disease management, and sustainable care models.
Governments and healthcare providers throughout the GCC are focusing on long-term health outcomes and preventive care strategies to address rising rates of obesity and related metabolic conditions.
Endocare’s expansion aligns closely with these regional priorities, positioning the company as a comprehensive platform for advanced metabolic care across multiple markets.
The partnership with The Clinics demonstrates how established healthcare providers in the region are collaborating with specialized operators to enhance service offerings and meet evolving patient needs in the growing metabolic health sector.
Be the first to leave a comment